Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Minnesota
OBJECTIVES:
* Measure plasma cathepsin D levels in patients with non-small cell lung cancer and in healthy volunteers using mass spectometry.
* Measure fatty acid synthase levels in these patients and healthy volunteers using mass spectometry.
OUTLINE: Blood samples are collected from patients and healthy volunteers to measure the levels of cathepsin D and fatty acid synthase by proteomic profiling and mass spectrometry.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Non-Small Cell Lung Cancer Patients
Documented diagnosis of non-small cell lung cancer, any stage and any time point in the course of treatment (i.e., at diagnosis, during any treatment, and during post treatment surveillance)
Measurable disease by CT scan within the past 4 weeks
Healthy volunteer
Non-smoking, defined as \< 5 packs/year history of smoking and cessation of smoking ≥ 6 months ago OR a never smoker
* Not regularly exposed (i.e., daily) to second-hand smoke
You may not be if
Severe underlying lung disease (i.e., chronic obstructive pulmonary disease with FEV\_1 \< 1.0 L, pulmonary fibrosis, bronchiectasis, cystic fibrosis, etc.) as determined by enrolling researcher.
Written consent must be given for both subjects and controls.
Clareo Health | Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
